For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220510:nRSJ8568Ka&default-theme=true
RNS Number : 8568K AMTE Power PLC 10 May 2022
10 May 2022
AMTE POWER PLC
("AMTE Power" or the "Company")
Appointment of Joint Broker
AMTE Power Plc ("AMTE Power" or the "Company"), the developer and manufacturer
of lithium-ion and sodium-ion battery cells for specialist market, is pleased
to announce the appointment, with immediate effect, of Panmure Gordon as the
Company's Joint Broker, alongside WH Ireland, who will retain their role as
NOMAD and Joint Broker.
Enquiries
AMTE Power plc Tel: +44 (0)1847 867 200
Kevin Brundish (Chief Executive Officer)
James Hobson (Chief Financial Officer)
Panmure Gordon (UK) Limited (Joint Broker) Tel: +44 (0)207 886 2500
John Prior / Harriette Johnson (Corporate Finance)
Hugh Rich (Corporate Broking)
WH Ireland (NOMAD and Joint Broker) Tel: +44 (0)207 220 1666
Chris Fielding / Ben Good
Camarco Tel: +44 (0)20 3757 4992
Ginny Pulbrook / Tom Huddart / Rosie Driscoll
Notes to Editors:
AMTE Power was founded in 2013 and is a leading developer and manufacturer of
lithium-ion and sodium-ion battery cells for specialist markets. In March
2021, the Company listed on the AIM market of the London Stock Exchange. The
Company is focused on launching a series of next generation battery cells
based on new chemistries and cell structures that are designed to solve key
problems in power delivery, energy performance, and safety. These new products
are targeted at a range of specialist markets including the electric vehicle
industry and energy storage sector. AMTE Power's purpose-built cell
manufacturing facility in Thurso, Scotland has the second largest cell
manufacturing capacity in the UK and the Company also has a product
development team based in Oxford.
For further information visit the Company's website: www.amtepower.com
(http://www.amtepower.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END APPUKUWRUOUVRAR